OpportunityTitle: Developmental Pharmacology (R03)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:   Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Cancer Institute (NCI), National Institute of Environmental Health Sciences (NIEHS),National Institutes of Health (NIH) invite grant applications for research related to developmental pharmacology. A major aim of this FOIA is to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity across developmental periods from fetal life to adolescence.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;